Status:
COMPLETED
Efficacy and Safety of ReLEx Smile for Laser Correction of Myopia
Lead Sponsor:
University of Aarhus
Conditions:
Myopia
Eligibility:
All Genders
18-80 years
Brief Summary
Evaluation of the safety and efficacy of the Carl Zeiss Meditec VisuMax femtosecond laser for lamellar resection (ReLEx smile) in the reduction of myopia.
Detailed Description
Quality control study of patients treated with ReLEx smile for myopia at the Department of Ophthalmology, Aarhus University Hospital. The patients will be followed with standard clinical techniques (...
Eligibility Criteria
Inclusion
- Indication for keratorefractive correction of myopia
- Patient consent to undergo keratorefractive correction of myopia
Exclusion
- Pregnant or lactating women
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT01481792
Start Date
February 1 2011
End Date
October 1 2015
Last Update
May 12 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Aarhus University Hospital
Aarhus C, Denmark, 8000